<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02177370</url>
  </required_header>
  <id_info>
    <org_study_id>260.716</org_study_id>
    <nct_id>NCT02177370</nct_id>
  </id_info>
  <brief_title>Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma</brief_title>
  <official_title>Effect of Fenoterol Metered Dose Inhaler (0.1 mg) on the Beta-receptor Population on Lymphocytes and the Clinical Findings Compared With Treatment With DSCG Metered Dose Inhaler in Patients With Bronchial Asthma.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boehringer Ingelheim</source>
  <brief_summary>
    <textblock>
      The aim of the study was to compare the effect of fenoterol metered dose inhaler with
      disodium cromoglycate (DSCG) metered dose inhaler on the lymphocyte β2-receptor population as
      well as on the clinical findings in patients with bronchial asthma over a two-week period of
      treatment.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>February 1990</start_date>
  <primary_completion_date type="Actual">October 1996</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Airway resistance (Raw)</measure>
    <time_frame>after 2 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of binding sites of the β2 receptors per lymphocytes (BS/LY)</measure>
    <time_frame>after 2 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Fenoterol metered dose inhaler (MDI)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>DSCG MDI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fenoterol MDI</intervention_name>
    <arm_group_label>Fenoterol metered dose inhaler (MDI)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DSCG MDI</intervention_name>
    <arm_group_label>DSCG MDI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  sex: male and female

          -  age: 18 years or over

          -  bronchial asthma, diagnosis confirmed by history and positive inhalation challenge
             test (unspecific challenge with carbachol, PD100SRaw))

          -  severity of asthma mild to moderate or asthmatic in symptom-free intervals

          -  Raw ≤ 5 cm H2O/l/s

          -  no antiasthmatic treatment in the week (steroid therapy: two weeks) before the start
             of the study

        Exclusion Criteria:

          -  clinically significant, concomitant haematological, cardiac, renal, hepatic or
             metabolic diseases

          -  intercurrent diseases, e.g. severe respiratory infections

          -  patients who cannot do without the following preparations during the 5-week trial:

               -  inhaled/oral steroids

               -  theophylline

               -  antihistamine, antiallergic drugs

               -  inhaled/oral sympathomimetics

               -  anticholinergics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <link>
    <url>http://trials.boehringer-ingelheim.com</url>
  </link>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2014</study_first_submitted>
  <study_first_submitted_qc>June 26, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2014</study_first_posted>
  <last_update_submitted>July 17, 2014</last_update_submitted>
  <last_update_submitted_qc>July 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 18, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fenoterol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

